Published in Ann Surg on July 01, 1975
Clinical examination, xeromammography, and fine-needle aspiration cytology in diagnosis of breast tumours. Br Med J (1978) 1.44
Fine needle aspiration in breast lumps. Ulster Med J (1982) 0.91
The place of subcutaneous mastectomy with immediate silicone prosthetic implantation in diseases of the breast. Ann R Coll Surg Engl (1980) 0.90
Survival and recurrences five years after selective treatment for breast carcinoma. Br J Cancer (1978) 0.89
Assessment of a scoring scheme for the preoperative diagnosis of breast lumps. Ann R Coll Surg Engl (1984) 0.88
Cost-effectiveness of fine needle biopsy of the breast. Ann Surg (1986) 0.86
Consent for mastectomy. Br Med J (1980) 0.79
Out-patient breast biopsies. Ann Surg (1977) 0.75
Aspiration biopsy in diagnosis of palpable lesions of the breast. Critical review of 3479 consecutive biopsies. Acta Radiol Ther Phys Biol (1968) 3.25
Adequacies and inadequacies of breast examinations by physicians. Cancer (1969) 1.60
Increased detection of occult breast carcinoma after more thorough histologic examination of breast biopsies. Am J Clin Pathol (1973) 1.18
An analysis of 1500 breast biopsies. Am Surg (1960) 1.03
The cytological diagnosis of solid tumours by small needle aspiration and its influence on cancer clinic practice. Can Med Assoc J (1959) 0.93
Cytologic diagnosis of mammary tumors from aspiration biopsy smears. Comparison of cytologic and histologic findings in 2,III lesions and diagnostic use of cytophotometry. Acta Cytol (1971) 0.91
Treatment of early cancer of the breast. Postgrad Med (1960) 0.90
The role of excision biopsy in lesions of the breast. Am Surg (1952) 0.88
Radiography of breast specimens. Cancer (1971) 0.86
Mammography: an aid in the treatment of carcinoma of the breast. Ann Surg (1974) 0.85
[Cyto-radio-clinical triple diagnosis of breast tumors (apropos of 2,460 cases)]. Mem Acad Chir (Paris) (1969) 0.84
[Cytodiagnosis of cancer of the breast]. Minerva Ginecol (1971) 0.82
Cytologic studies of aspiration biopsy of the breast. Critical review of 2,890 consecutive biopsies. Minerva Ginecol (1971) 0.82
[New handle for single injections. Fine needle for everyday use]. Lakartidningen (1971) 0.82
CRITICAL EVALUATION OF MAMMOGRAPHY IN THE MANAGEMENT OF BREAST DISEASE. Ann Surg (1965) 0.82
X-ray and fine-needle biopsy in diagnosis of non-palpable breast lesions. Acta Cytol (1975) 0.82
Adequate breast biopsy; experience in one thousand consecutive personal cases. AMA Arch Surg (1953) 0.81
[Diagnosis of benign and malignant breast neoplasms. Results of combined clinical, mammographic and cytological examination (triple diagnosis)]. Dtsch Med Wochenschr (1973) 0.81
[Puncture biopsy for mammary carcinoma]. Fortschr Geb Rontgenstr Nuklearmed (1973) 0.81
Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med (1999) 17.30
Breast cancer screening with mammography: overview of Swedish randomised trials. Lancet (1993) 9.88
Complete sequencing of the p53 gene provides prognostic information in breast cancer patients, particularly in relation to adjuvant systemic therapy and radiotherapy. Nat Med (1995) 5.85
Body mass index as a predictor of fracture risk: a meta-analysis. Osteoporos Int (2005) 5.54
Evaluating gastric cancer misclassification: a potential explanation for the rise in cardia cancer incidence. J Natl Cancer Inst (1999) 3.13
Helicobacter pylori infection: independent risk indicator of gastric adenocarcinoma. Gastroenterology (1993) 2.64
10-Year results after sector resection with or without postoperative radiotherapy for stage I breast cancer: a randomized trial. J Clin Oncol (1999) 2.64
The role of tobacco, snuff and alcohol use in the aetiology of cancer of the oesophagus and gastric cardia. Int J Cancer (2000) 2.58
The p53 gene in breast cancer: prognostic value of complementary DNA sequencing versus immunohistochemistry. J Natl Cancer Inst (1996) 2.57
Test-retest variability in glaucomatous visual fields. Am J Ophthalmol (1989) 2.40
Prognostic and predictive value of c-erbB-2 overexpression in primary breast cancer, alone and in combination with other prognostic markers. J Clin Oncol (1998) 2.09
Risk of endometrial cancer following estrogen replacement with and without progestins. J Natl Cancer Inst (1999) 1.73
Effect of thiol oxidation and thiol export from erythrocytes on determination of redox status of homocysteine and other thiols in plasma from healthy subjects and patients with cerebral infarction. Clin Chem (1995) 1.71
Analysis of reproducibility of subjective grading systems for breast carcinoma. J Clin Pathol (1979) 1.65
Body size in different periods of life, diabetes mellitus, hypertension, and risk of postmenopausal endometrial cancer (Sweden). Cancer Causes Control (2000) 1.61
Local breast cancer recurrence caused by mammographically guided punctures. Acta Radiol (2000) 1.59
Mammographic screening for breast cancer. What cancers do we find? Eur J Cancer (1997) 1.58
Predicting breast cancer recurrence. Cancer (1982) 1.57
Evidence of a modifying influence of heart glucosides on the development of breast cancer. Anal Quant Cytol (1980) 1.53
Diastolic blood pressure and area of residence: multilevel versus ecological analysis of social inequity. J Epidemiol Community Health (2001) 1.52
Risk factors for local recurrence after conservative treatment in stage I breast cancer. Definition of a subgroup not requiring radiotherapy. Ann Oncol (1997) 1.51
Papanicolaou smear screening and cervical cancer. What can you expect? JAMA (1984) 1.48
Prevalence and intensity of pain after stroke: a population based study focusing on patients' perspectives. J Neurol Neurosurg Psychiatry (2005) 1.48
Use of oral contraceptives and endometrial cancer risk (Sweden). Cancer Causes Control (1999) 1.42
Addition of calcium to Euro-Collins solution is essential for 24-hour preservation of the vasculature. Ann Thorac Surg (1997) 1.41
Vitamin B12 metabolism after urinary diversion with a Kock ileal reservoir. Scand J Urol Nephrol (2001) 1.39
Malignant and benign human mammary disease: estrogen binding in relation to clinical data. Cancer (1974) 1.39
Whatever happened to cervical cytology automation? Anal Cell Pathol (1990) 1.39
[A complication in Budd-Chiari syndrome. Heparin therapy caused thrombocytopenia]. Lakartidningen (1994) 1.39
Risk of endometrial cancer after treatment with oestrogens alone or in conjunction with progestogens: results of a prospective study. BMJ (1989) 1.39
A new method for the diagnosis of systemic amyloidosis. Arch Intern Med (1973) 1.38
Histopathological systems of breast cancer classification: reproducibility and clinical significance. J Clin Pathol (1983) 1.34
Reproductive history and risk of breast cancer: a case-control study in an unselected Swedish population. Cancer (1978) 1.33
Cancer of the nasal cavity and paranasal sinuses: a series of 115 patients. Rhinology (1998) 1.33
Diagnosis of secondary generalized amyloidosis by fine needle biopsy of the skin. Acta Med Scand (1971) 1.28
Management and prognostic features of intracerebral hemorrhage during anticoagulant therapy: a Swedish multicenter study. Stroke (2001) 1.26
Cardiac glycosides and breast cancer, revisited. N Engl J Med (1982) 1.26
Nutrients and gastric cancer risk. A population-based case-control study in Sweden. Int J Cancer (1994) 1.25
Requirement for coenzyme Q in plasma membrane electron transport. Proc Natl Acad Sci U S A (1992) 1.25
Perfusion-related parameters in intravoxel incoherent motion MR imaging compared with CBV and CBF measured by dynamic susceptibility-contrast MR technique. Acta Radiol (2001) 1.23
Cytological differentiation of asymptomatic pancreatic islet cell tumours in autopsy material. Virchows Arch A Pathol Anat Histol (1975) 1.22
Early-life risk indicators of gastric cancer. A population-based case-control study in Sweden. Int J Cancer (1994) 1.17
Risk factors and treatment at recurrent stroke onset: results from the Recurrent Stroke Quality and Epidemiology (RESQUE) Study. Cerebrovasc Dis (2008) 1.17
Cardiac glycosides and breast cancer. Lancet (1979) 1.16
Prognostic characteristics in breast cancers after hormone replacement therapy. Breast Cancer Res Treat (1996) 1.16
Determination of cause of death among breast cancer cases in the Swedish randomized mammography screening trials. A comparison between official statistics and validation by an endpoint committee. Acta Oncol (1995) 1.15
Perimetric probability maps to separate change caused by glaucoma from that caused by cataract. Acta Ophthalmol Scand (1997) 1.14
Breast cancer: prognostic significance of c-erb-B2 and int-2 amplification compared with DNA ploidy, S-phase fraction, and conventional clinicopathological features. Breast Cancer Res Treat (1994) 1.12
Influence of height, weight and obesity on risk of breast cancer in an unselected Swedish population. Br J Cancer (1977) 1.11
Familiality in breast cancer: a case-control study in a Sweden population. Br J Cancer (1980) 1.09
Lund Stroke Register: hospitalization pattern and yield of different screening methods for first-ever stroke. Acta Neurol Scand (2007) 1.09
Homocysteine and cysteine: determinants of plasma levels in middle-aged and elderly subjects. J Intern Med (1994) 1.09
Prognostic significance of c-erb-B2 amplification in fine-needle biopsies of breast cancer patients not operated at diagnosis. Breast Cancer Res Treat (1996) 1.09
Demonstration of gene-amplification by PCR in archival paraffin-embedded breast cancer tissue. Breast Cancer Res Treat (1994) 1.08
Risk factors for local recurrence after breast-conserving surgery. Br J Surg (2003) 1.08
Low-potency oestrogen and risk of endometrial cancer: a case-control study. Lancet (1999) 1.07
Prevalence of Helicobacter pylori infection in subtypes of gastric cancer. Gastroenterology (1995) 1.07
Characteristics of familial breast cancer in Sweden: absence of relation to age and unilateral versus bilateral disease. Cancer (1981) 1.04
Detection and temporal appearance of multiple copies of c-erb-B2 genes in advanced mammary carcinoma using fine needle biopsies and the polymerase chain reaction. Breast Cancer Res Treat (1992) 1.04
Computerized nuclear morphometry as an objective method for characterizing human cancer cell populations. Cancer Res (1978) 1.03
Plasma homocysteine in acute myocardial infarction: homocysteine-lowering effect of folic acid. J Intern Med (1995) 1.03
Prognostic value of amplification of c-erb-B2 in bladder carcinoma. Clin Cancer Res (1995) 1.01
Thyroid disease and function in breast cancer patients and non-hospitalized controls evaluated by determination of TSH, T3, rT3 and T4 levels in serum. Acta Chir Scand (1978) 0.99
Assessment of regional cerebral blood flow by dynamic susceptibility contrast MRI using different deconvolution techniques. Magn Reson Med (2000) 0.99
Prognostic value of erb-B2 and myc amplification in breast cancer imprints. Cancer (1995) 0.97
Reproducibility in DNA flow cytometric analysis of breast cancer: comparison of 12 laboratories' results for 67 sample homogenates. Cytometry (1995) 0.97
Subdivision of the G1 phase of human glia cells in culture. Exp Cell Res (1976) 0.97
Cardenolides and cancer. Anticancer Drugs (2001) 0.97
Persistent high signal on diffusion-weighted MRI in the late stages of small cortical and lacunar ischaemic lesions. Neuroradiology (2001) 0.97
Incidence of intracerebral and subarachnoid haemorrhage in southern Sweden. J Neurol Neurosurg Psychiatry (2000) 0.97
Heredity and risk of cancer of the esophagus and gastric cardia. Cancer Epidemiol Biomarkers Prev (2000) 0.97
Autoradiographic studies on the distribution of arsenic in mice and hamsters administered 74As-arsenite or -arsenate. Acta Pharmacol Toxicol (Copenh) (1982) 0.97
Prognostic implication of estrogen receptor content in breast cancer. Breast Cancer Res Treat (1985) 0.96
Occupational exposures and risk of gastric cancer in a population-based case-control study. Cancer Res (1999) 0.95
Diet and risk of gastric cancer. A population-based case-control study in Sweden. Int J Cancer (1993) 0.95
Association of a lack of psychosocial resources and the risk of giving birth to small for gestational age infants: a stress hypothesis. BJOG (2000) 0.95
Symptoms and signs in benign and malignant tumours of the breast. Ups J Med Sci (1976) 0.95
Embryotoxicity of arsenite and arsenate: distribution in pregnant mice and monkeys and effects on embryonic cells in vitro. Acta Pharmacol Toxicol (Copenh) (1984) 0.94
Increased stroke incidence in Lund-Orup, Sweden, between 1983 to 1985 and 1993 to 1995. Stroke (2000) 0.93
Costs of on-demand and prophylactic treatment for severe haemophilia in Norway and Sweden. Haemophilia (2004) 0.93
Involvement of transferrin in the reduction of iron by the transplasma membrane electron transport system. J Bioenerg Biomembr (1987) 0.93
p53 Status predicts survival in breast cancer patients treated with or without postoperative radiotherapy: a novel hypothesis based on clinical findings. J Clin Oncol (1995) 0.93
Mammographic finding as predictor of survival in 1-9 mm invasive breast cancers. worse prognosis for cases presenting as calcifications alone. Breast Cancer Res Treat (2001) 0.93
Liver involvement in Addison's disease. Am J Gastroenterol (1990) 0.92
Can endoscopic biopsy specimens be used for reliable Laurén classification of gastric cancer? Scand J Gastroenterol (1996) 0.92
Prognostic factors in canine mammary tumors: a multivariate study of 202 consecutive cases. Vet Pathol (1993) 0.92
Hyperhomocysteinaemia in stroke: prevalence, cause, and relationships to type of stroke and stroke risk factors. Eur J Clin Invest (1992) 0.92
Correlation between cytometric features and mitotic frequency in human breast carcinoma. Cytometry (1981) 0.92
Pleural plaques: correlation of autopsy findings to radiographic findings and occupational history. Eur J Respir Dis (1980) 0.91
Deficient antigen presentation by Langerhans cells from athymic (nu/nu) mice. Restoration with thymic transplantation or administration of cytokines. J Immunol (1993) 0.90
The risk of endometrial neoplasia and treatment with estrogens and estrogen-progestogen combinations. First results of a cohort study after one to four completed years of observation. Acta Obstet Gynecol Scand (1986) 0.90
Accumulation of toxic metals in male reproduction organs. Arch Toxicol Suppl (1984) 0.90
Peroperative diagnosis of axillary lymph nodes in cancer of the breast. Surg Gynecol Obstet (1974) 0.90
Multifocal breast carcinoma. Am J Surg (1981) 0.90
Intratumoral heterogeneity for amplified genes in human breast carcinoma. Int J Cancer (1994) 0.89
Survival and recurrences five years after selective treatment for breast carcinoma. Br J Cancer (1978) 0.89